Day 3: Congress: Monday, November 11, 2019

Panel Session 2: Menopause Panel: Updates, Emerging Therapies, and Challenging Cases


Monday, November 11, 2019


4:10 pm – 5:10 pm


Rooms 118-120




Kate A. O’Hanlan


Pelin Batur, Timothy C. Rowe, Ralph J. Turner

Course Description

This session will provide the surgeon with an update on the risks and benefits of hormone therapy for surgical and natural menopause and review the non-hormonal emerging therapies.  The role of systemic and vaginal estrogens and of androgen treatments will be reviewed, as well as a discussion of complex case scenarios (i.e. thromboembolism, cancer, severe endometriosis). The session will include an interdisciplinary group of menopause specialists and is intended to promote an informal, open discussion of controversies, differing practice styles and a dialogue on any clinical challenges the audience would like to address.

Course Objectives

At the conclusion of this activity, the participant will be able to: 1) Effectively counsel patients deciding about ovary removal and to manage symptomatic menopause, especially in complex medical scenarios.

Course Outline

4:10Welcome, Introductions, and Course OverviewK.A. O’Hanlan
4:15Estrogen – More than a Sex Hormone from the OvaryR.J. Turner
4:25Androgen Therapy in Menopausal WomenT.C. Rowe
4:35Seeing the Big Picture with the Complicated PatientP. Batur
4:45Panel DiscussionAll Faculty